4.3 Article

Factors associated with long-term benzodiazepine and Z-drug use across the lifespan and 5-year temporal trajectories among incident users: a Swedish nationwide register-based study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pharmacology & Pharmacy

Use of benzodiazepines and benzodiazepine-related drugs in the Nordic countries between 2000 and 2020

Mikkel Hojlund et al.

Summary: The use of benzodiazepines and related drugs has decreased in the Nordic countries from 2004 to 2020, with significant differences between countries. Despite warnings, benzodiazepines are still commonly used in the older population.

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2023)

Article Health Policy & Services

Walking the Benzodiazepine High Wire

Kurt Kroenke et al.

Summary: The use of benzodiazepine (BZD) prescriptions has increased significantly in the past decade, leading to higher rates of misuse and overdose. This has prompted regulatory changes and prescribing guideline revisions. Clinical trials provide strong evidence for the anxiolytic efficacy of BZDs, making them useful for treating acute or severe and persistent anxiety. Education for healthcare providers and patients, along with prescribing surveillance, may be a preferable approach to regulating BZD use than strict regulations.

PSYCHIATRIC SERVICES (2023)

Article Medicine, General & Internal

Benzodiazepines and Related Sedatives

Linda Peng et al.

MEDICAL CLINICS OF NORTH AMERICA (2022)

Article Clinical Neurology

Short-term and long-term efficacy and safety of antiseizure medications in Lennox Gastaut syndrome: A network meta-analysis

Nagita Devi et al.

Summary: This study assessed the short-term and long-term efficacy and safety of antiseizure medications (ASMs) for Lennox-Gastaut syndrome (LGS). The results suggest that high-dose clobazam (CLB_H), cannabidiol (CBD), and rufinamide (RFM) are the most effective and safest options in terms of both short and long-term outcomes.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2022)

Article Public, Environmental & Occupational Health

Effects of 'doctor shopping' behaviour on prescription of addictive drugs in Sweden

Yana Zykova et al.

Summary: Free choice of health care providers can improve the quality of health care, but it can also lead to doctor shopping behavior and abuse of prescription drugs. A study in Sweden found that patients visiting different providers received up to three additional doses of prescription drugs per day on average.

SOCIAL SCIENCE & MEDICINE (2022)

Article Public, Environmental & Occupational Health

Increasing prevalence of illicit drug use among employees at Swedish workplaces over a 25-year period

Kristin Feltmann et al.

Summary: The use of illicit drugs among employees in Swedish workplaces has increased over a 25-year period.

EUROPEAN JOURNAL OF PUBLIC HEALTH (2022)

Review Geriatrics & Gerontology

Is there a link between the use of benzodiazepines and related drugs and dementia? A systematic review of reviews

Patricia Ferreira et al.

Summary: The use of BZDs/BZRDs may increase the risk of cognitive decline and dementia in older adults, caution should be exercised when prescribing these drugs to reduce this risk.

EUROPEAN GERIATRIC MEDICINE (2022)

Editorial Material Psychiatry

Benzodiazepines: it's time to return to the evidence

Edward Silberman et al.

Summary: The current discussions on benzodiazepines in psychiatric literature have shown a negative bias and deviated from the scientific evidence base. It is recommended to return to the evidence and adhere to clear definitions and conceptual rigor when discussing benzodiazepines.

BRITISH JOURNAL OF PSYCHIATRY (2021)

Article Medicine, General & Internal

Risk of long-term benzodiazepine and Z-drug use following the first prescription among community-dwelling adults with anxiety/mood and sleep disorders: a retrospective cohort study

Jaden Brandt et al.

Summary: A retrospective study in Manitoba on long-term benzodiazepine receptor agonist (BZRA) use among individuals with anxiety, mood, and/or sleep disorders found that less than 20% of patients used BZRAs for 180 days or more in their first treatment episode. Factors associated with long-term use included male sex, age 65 and older, receiving income assistance, previous use of non-BZRA psychotropic or opioid medications, high comorbidity, high healthcare utilization, and being prescribed by a psychiatrist.

BMJ OPEN (2021)

Article Primary Health Care

Rote of the prescriber in supporting patients to discontinue benzodiazepines: a qualitative study

Erin Oldenhof et al.

Summary: The study investigated patients' perceptions of their prescribers' influence on ceasing BZD use and found that patients are willing to try reducing BZD if they trust their prescriber. Patients at different stages of change experience different barriers and facilitators to reducing BZD use.

BRITISH JOURNAL OF GENERAL PRACTICE (2021)

Article Pharmacology & Pharmacy

Patterns and Predictors of Off-Label Drug Prescribing in Psychiatric Practice: A Qualitative Study

Sadia Shakeel et al.

Summary: This study investigated psychiatrists' perceptions of off-label drug prescribing in clinical practice. The findings revealed that doctors have knowledge of off-label drugs, varied attitudes towards them, and consider their usage common in psychiatry. Most respondents did not inform patients before prescribing off-label drugs. Further education and awareness are needed to prevent risks associated with off-label drug prescribing in regions with limited knowledge.

PHARMACY (2021)

Article Medicine, General & Internal

Benzodiazepines for the long-term treatment of anxiety disorders?

Prashant Tibrewal et al.

LANCET (2021)

Article Medicine, General & Internal

Benzodiazepines for the long-term treatment of anxiety disorders? – Authors' reply

Brenda W J H Penninx et al.

LANCET (2021)

Article Clinical Neurology

Benzodiazepines: Uses, Dangers, and Clinical Considerations

Amber N. Edinoff et al.

Summary: Benzodiazepines are widely prescribed psychoactive drugs known for their sedative effects on the central nervous system. Despite their effectiveness in treating various conditions, they have a high potential for addiction and withdrawal symptoms, requiring careful tapering of the medication. Future research is needed to explore alternative methods for treating BZD withdrawal due to the increasing number of individuals seeking treatment for BZD dependence in the United States.

NEUROLOGY INTERNATIONAL (2021)

Article Clinical Neurology

Different Attitudes of Patients and Psychiatrists Toward Benzodiazepine Treatment

Yasushi Kawamata et al.

Summary: This study aimed to understand the attitudes of patients and psychiatrists towards long-term use of BDZs, revealing discrepancies in their perceptions of reducing BDZ dose. Promoting patient-centered care to reduce BDZ use, including patient psychoeducation and guidance on decision-making processes, is necessary.

NEUROPSYCHIATRIC DISEASE AND TREATMENT (2021)

Article Medicine, General & Internal

Incidence of and Characteristics Associated With Long-term Benzodiazepine Use in Finland

Heidi Taipale et al.

JAMA NETWORK OPEN (2020)

Article Primary Health Care

Physicians' beliefs and attitudes about Benzodiazepines: a cross-sectional study

Ines Teixeira Neves et al.

BMC FAMILY PRACTICE (2019)

Review Pharmacology & Pharmacy

Effectiveness and safety of long-term benzodiazepine use in anxiety disorders: a systematic review and meta-analysis

Masaki Shinfuku et al.

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2019)

Article Public, Environmental & Occupational Health

Prescription Benzodiazepine Use in Privately Insured US Children and Adolescents

Greta A. Bushnell et al.

AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2019)

Article Psychiatry

Trajectory analysis of anxiolytic dispensing over 10 years among new users aged 50 and older

P. Verger et al.

ACTA PSYCHIATRICA SCANDINAVICA (2018)

Review Pharmacology & Pharmacy

Potentially inappropriate medication in the elderly: a systematic review of validated explicit criteria

Fabiane Raquel Motter et al.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2018)

Article Psychiatry

What can predict and prevent the long-term use of benzodiazepines?

Takeo Hata et al.

JOURNAL OF PSYCHIATRIC RESEARCH (2018)

Review Geriatrics & Gerontology

Fall-Risk-Increasing Drugs: A Systematic Review and Meta-Analysis: II. Psychotropics

Lotta J. Seppala et al.

JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2018)

Letter Medicine, General & Internal

Factors AssociatedWith Long-term Benzodiazepine Use Among Older Adults

Lauren B. Gerlach et al.

JAMA INTERNAL MEDICINE (2018)

Article Public, Environmental & Occupational Health

Trends in incident use of benzodiazepines and Z-drugs in France from 2006 to 2012: a population-based study

Anne Benard-Laribiere et al.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2017)

Review Medicine, General & Internal

Treatment of Benzodiazepine Dependence

Michael Soyka

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Medicine, General & Internal

Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis

Eric C. Sun et al.

BMJ-BRITISH MEDICAL JOURNAL (2017)

Article Medicine, General & Internal

Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis

Eric C. Sun et al.

BMJ-BRITISH MEDICAL JOURNAL (2017)

Article Pharmacology & Pharmacy

Long-term use of benzodiazepines in older patients in Germany: a retrospective analysis

Louis Jacob et al.

THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2017)

Article Health Care Sciences & Services

Provider Patient-Sharing Networks and Multiple-Provider Prescribing of Benzodiazepines

Mei-Sing Ong et al.

JOURNAL OF GENERAL INTERNAL MEDICINE (2016)

Review Clinical Neurology

The Role of Benzodiazepines in the Treatment of Epilepsy

Juan G. Ochoa et al.

CURRENT TREATMENT OPTIONS IN NEUROLOGY (2016)

Article Pharmacology & Pharmacy

Comorbidities and concurrent medications increasing the risk of adverse drug reactions: prevalence in French benzodiazepine users

Anne Benard-Laribiere et al.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2016)

Article Health Policy & Services

Sustained Use of Benzodiazepines and Escalation to High Doses in a Canadian Population

Silvia Alessi-Severini et al.

PSYCHIATRIC SERVICES (2016)

Article Neurosciences

Exposure to psychotropic medications prior to overdose: a case-control study

Yasuyuki Okumura et al.

PSYCHOPHARMACOLOGY (2015)

Letter Psychiatry

Need for a realistic appraisal of benzodiazepines

Richard Balon et al.

WORLD PSYCHIATRY (2015)

Article Pharmacology & Pharmacy

Benzodiazepine prescribing guideline adherence and misuse potential in Irish minors

Kevin D. Murphy et al.

INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2015)

Review Pharmacology & Pharmacy

Benzodiazepine harm: how can it be reduced?

Malcolm Lader

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)

Article Geriatrics & Gerontology

The elimination half-life of benzodiazepines and fall risk: two prospective observational studies

Oscar J. de Vries et al.

AGE AND AGEING (2013)

Article Pharmacology & Pharmacy

Use of addictive anxiolytics and hypnotics in a national cohort of incident users in Norway

Svein R. Kjosavik et al.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2012)

Article Pharmacology & Pharmacy

A Randomized, Naturalistic, Parallel-Group Study for the Long-Term Treatment of Panic Disorder With Clonazepam or Paroxetine

Antonio E. Nardi et al.

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2012)

Article Medicine, General & Internal

Medication for Attention Deficit-Hyperactivity Disorder and Criminality

Paul Lichtenstein et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Psychology, Clinical

Group-Based Trajectory Modeling in Clinical Research

Daniel S. Nagin et al.

ANNUAL REVIEW OF CLINICAL PSYCHOLOGY, VOL 6 (2010)

Review Medicine, General & Internal

Benzodiazepines for alcohol withdrawal

Laura Amato et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2010)

Article Public, Environmental & Occupational Health

The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research

Jonas F. Ludvigsson et al.

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2009)

Article Pharmacology & Pharmacy

Dispensing of anxiolytics and hypnotics in southeastern France: demographic factors and determinants of geographic variations

Aurelie Bocquier et al.

FUNDAMENTAL & CLINICAL PHARMACOLOGY (2008)

Article Medicine, General & Internal

Patterns of Abuse Among Unintentional Pharmaceutical Overdose Fatalities

Aron J. Hall et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)

Review Primary Health Care

Thou shalt versus thou shalt not: a meta-synthesis of GPs' attitudes to clinical practice guidelines

Benedicte Carlsen et al.

BRITISH JOURNAL OF GENERAL PRACTICE (2007)

Article Public, Environmental & Occupational Health

The new Swedish Prescribed Drug Register -: Opportunities for pharmacoepidemiological research and experience from the first six months

Bjorn Wettermark et al.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)